Dong-A Q2 sales rise 9.8%

Published: 2012-07-31 06:57:00

Updated: 2012-07-31 06:57:00

Dong-A Pharmaceutical, the country’s top drug maker, said Friday its sales climbed 9.8 percent on-year to 246.5 billion won in the second quarter, fueled by booming demand for over-the-counter (OTC) drugs and overseas sales as well as strategic alliances with GlaxoSmithKline and Bayer.

Operating profit in the April-June period declined 46 percent to 16.2 billion won from a year earlier on a ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.